← Back to Search

Other

Shoulder Pacemaker for Dyskinesia

N/A
Waitlist Available
Led By Robert Z Tashjian, MD
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Scapular Dyskinesis
Posterior Shoulder Instability
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12-months
Awards & highlights

Study Summary

This trial is testing a shoulder pacemaker to see if it can help improve symptoms in patients with Scapular Dyskinesis or Posterior Shoulder Instability.

Who is the study for?
This trial is for individuals with Scapular Dyskinesis or Posterior Shoulder Instability who haven't found relief through other treatments. It's not suitable for those with rotator cuff tears, shoulder arthritis, or anyone using implantable or wearable electrical medical devices like pacemakers and glucose sensors.Check my eligibility
What is being tested?
The study is testing a 'shoulder pacemaker' to see if it can improve pain and movement in patients with shoulder dyskinesia. Participants will undergo rehabilitation using this device, and their pain levels will be monitored to assess effectiveness.See study design
What are the potential side effects?
While the specific side effects of the shoulder pacemaker are not detailed here, similar devices may cause discomfort at the site of application, muscle spasms, skin irritation from adhesive pads, or unexpected changes in muscle movements.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have abnormal movement in my shoulder blade.
Select...
My shoulder is unstable and tends to dislocate backwards.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12-months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12-months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Visual Analog Scale (VAS) pain

Trial Design

1Treatment groups
Experimental Treatment
Group I: Shoulder Pacemaker TreatmentExperimental Treatment1 Intervention
The patients will be treated using the pacemaker for 15 - 30 minutes at 3-months, 6-months and 12-months during physical therapy.

Find a Location

Who is running the clinical trial?

University of UtahLead Sponsor
1,099 Previous Clinical Trials
1,778,702 Total Patients Enrolled
Robert Z Tashjian, MDPrincipal InvestigatorUniversity of Utah Orthopaedics
2 Previous Clinical Trials
402 Total Patients Enrolled

Media Library

Shoulder Pacemaker (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05116722 — N/A
Scapular Dyskinesis Research Study Groups: Shoulder Pacemaker Treatment
Scapular Dyskinesis Clinical Trial 2023: Shoulder Pacemaker Highlights & Side Effects. Trial Name: NCT05116722 — N/A
Shoulder Pacemaker (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05116722 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Do I fulfill the prerequisites for participating in this experiment?

"This clinical trial is seeking approximately 20 individuals with scapular dyskinesis that range in age from 18 to 80."

Answered by AI

Are applications for participation still being accepted in this trial?

"The clinical trial page on clinicialtrials.gov indicates that this study, which was first advertised in September 2021 and last updated June 2022, is not currently accepting participants. However, there are still 36 other medical trials actively recruiting patients at the moment."

Answered by AI

Is there an age limit for enrollment in this research trial?

"According to the qualifications for this experiment, individuals must be between 18-80 years of age."

Answered by AI
~9 spots leftby Sep 2026